menu

Immune Thrombocytopenia: Updated Practice Guidelines in an Evolving Treatment Landscape

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Immune Thrombocytopenia: Updated Practice Guidelines in an Evolving Treatment Landscape

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

Two physicians discuss the ICR 2019 and ASH 2019 guidelines’ development, updates, and direction in which ITP management is heading.

  • Sponsored by

  • Overview

    There have been numerous developments and changes in the management approaches for immune thrombocytopenia (ITP), and the backbone of these approaches are centered around the ASH and ICR recommendations, which were recently updated in 2019. Join us as Drs. Gernsheimer and McCrae highlight key messages on the evolving treatment landscape and how the guidelines have followed suit.

    © 2021 Amgen Inc. All rights reserved. USA-531-80680 02/21

Schedule21 Oct 2021
Webpack App